ALT (Alanine Aminotransferase)
ALT is a liver enzyme measured in a standard blood test, and a mildly raised level is the most common first signal that fat is accumulating in the liver - which is why it is checked during weight management.
Plain English
Patient-Friendly Explanation
ALT stands for alanine aminotransferase. It is an enzyme that sits mainly inside liver cells, and when those cells are irritated or damaged they leak it into the bloodstream, where a blood test can measure it. In weight management, ALT is used as an early warning for fat building up inside the liver - a process that causes no symptoms and can be present for years before anything is felt. A mildly raised ALT is common in people carrying weight around the middle, particularly when blood sugar, blood pressure or cholesterol are also abnormal. It is not a diagnosis by itself: doctors read it with the other liver tests, and they usually repeat it after a few months, because ALT falls when weight comes down and the liver fat clears. Alcohol, some prescription medicines and herbal preparations, and other liver conditions can raise ALT too, so an abnormal result is always interpreted in context.
Medical
Clinical Definition
Alanine aminotransferase (ALT, formerly SGPT) is a transaminase that catalyses the reversible transfer of an amino group from alanine to alpha-ketoglutarate. It is present in hepatocyte cytoplasm and, less specifically, in kidney and skeletal muscle. Most laboratories in Singapore report a reference range of roughly 10 to 40 U/L, but sex-specific upper limits (about 30 U/L for men and 19 to 25 U/L for women) are preferred by AASLD and ACG guidance because the traditional cut-offs miss metabolic liver disease in a substantial proportion of patients. In the context of obesity, ALT is a first-line marker for MASLD: it is often normal in simple steatosis, typically rises with insulin resistance, visceral fat and metabolic syndrome, and correlates only loosely with histological severity - so a normal ALT does not exclude steatosis, steatohepatitis or fibrosis, and risk stratification with FIB-4 or elastography is required regardless. Interpretation: read ALT with AST (an AST/ALT ratio above 1 suggests advanced fibrosis in MASLD or an alcohol contribution), GGT, alkaline phosphatase, bilirubin, albumin and platelets. A mildly raised ALT (under five times the upper limit) in a patient with obesity does not usually need urgent hepatology referral but does need the obvious contributors excluded: alcohol, statins, paracetamol, some antibiotics, and herbal or traditional preparations, plus hepatitis B and C serology where not already documented. ALT is useful longitudinally: a 7 to 10 per cent loss of body weight lowers ALT and improves steatohepatitis on biopsy, so a falling ALT over three to six months is a low-cost, patient-visible signal that the liver is responding. In Singapore it is part of routine panel and employer health screening testing, which makes it a practical entry point for a weight and metabolic review.
Key Insight
Why It Matters
ALT is a cheap, familiar test that turns an invisible process - fat in the liver - into something a patient can watch fall as the weight comes off.
Where this fits
ALT (Alanine Aminotransferase) is one of the concepts that comes up in weight management at our clinic. If you are reading about it because of your own weight, the next practical step is a clinical assessment, see the doctor-led weight management programme for how the programme works, what it involves and what it costs.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.